Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Phase 3
Completed
- Registration Number
- CTRI/2009/091/000050
- Lead Sponsor
- This trial is being sponsored by BristolMyers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Men and women ≥ 18 years of age;
Clinical diagnosis of DVT or PE;
Anticoagulant treatment completed
No recurrence of VTE
Exclusion Criteria
Subjects with indications for long-term treatment with a vitamin K antagonist
Active bleeding or high risk for serious bleeding
Short life expectancy
Uncontrolled high blood pressure
Impaired kidney or liver function
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method